STOCK TITAN

Director at Polyrizon (PLRZ) sells 100 shares, retains 4,069

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Polyrizon Ltd. director Carmel Liron reported an open-market sale of 100 Ordinary Shares of Polyrizon on March 30, 2026 at $11.00 per share. After this transaction, Liron directly holds 4,069 ordinary shares, consisting of 1,463 ordinary shares and 2,606 restricted ordinary shares that vest in equal quarterly installments, subject to continued service.

Positive

  • None.

Negative

  • None.
Insider Carmel Liron
Role Director
Sold 100 shs ($1K)
Type Security Shares Price Value
Sale Ordinary Shares 100 $11.00 $1K
Holdings After Transaction: Ordinary Shares — 4,069 shares (Direct)
Footnotes (1)
  1. [object Object]
Shares sold 100 shares Open-market sale of Ordinary Shares on March 30, 2026
Sale price $11.00 per share Price for 100 Ordinary Shares sold
Shares owned after transaction 4,069 shares Total Ordinary Shares directly held following the sale
Unrestricted ordinary shares 1,463 shares Portion of Liron’s holdings that are ordinary, not restricted
Restricted ordinary shares 2,606 shares Restricted shares vesting quarterly, subject to continued service
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
restricted ordinary shares financial
"Consists of (i) 1,463 ordinary shares and (ii) 2,606 restricted ordinary shares"
Restricted ordinary shares are common stock that cannot be sold or transferred until certain conditions are met—such as a time period passing, performance targets being reached, or regulatory approvals—often issued to employees, founders, or early investors. They matter because those restrictions delay when the shares can enter the market, affecting the future supply of shares, potential dilution and company valuation; think of them as goods locked in a warehouse until release conditions are satisfied.
vest in equal installments financial
"restricted ordinary shares that vest in equal installments on a quarterly basis"
continued service financial
"vest in equal installments on a quarterly basis, subject to the Reporting Person's continued service"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Carmel Liron

(Last)(First)(Middle)
C/O POLYRIZON LTD.
9 HAPNINA STREET

(Street)
RAANANA4321546

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
Polyrizon Ltd. [ PLRZ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares03/30/2026S100D$114,069(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Consists of (i) 1,463 ordinary shares and (ii) 2,606 restricted ordinary shares that vest in equal installments on a quarterly basis, subject to the Reporting Person's continued service.
/s/ Liron Carmel03/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Polyrizon (PLRZ) disclose for Carmel Liron?

Polyrizon disclosed that director Carmel Liron executed an open-market sale of 100 Ordinary Shares at $11.00 per share on March 30, 2026. This Form 4 filing records the transaction and Liron’s updated share ownership position in the company.

How many Polyrizon (PLRZ) shares did Carmel Liron sell and at what price?

Carmel Liron sold 100 Ordinary Shares of Polyrizon at a price of $11.00 per share. The transaction was classified as an open-market sale and is reported as a non-derivative transaction in the Form 4 filing.

How many Polyrizon (PLRZ) shares does Carmel Liron own after the sale?

After the sale, Carmel Liron directly owns a total of 4,069 Ordinary Shares of Polyrizon. This total includes both currently held ordinary shares and restricted ordinary shares subject to vesting conditions tied to continued service.

What portion of Carmel Liron’s Polyrizon (PLRZ) holdings are restricted shares?

Out of Carmel Liron’s 4,069 total Ordinary Shares, 2,606 are restricted ordinary shares. These restricted shares vest in equal installments on a quarterly basis, provided Liron continues to serve in the relevant role with the company.

How many unrestricted Polyrizon (PLRZ) shares does Carmel Liron hold?

Carmel Liron holds 1,463 ordinary (unrestricted) shares of Polyrizon following the reported transaction. In addition, 2,606 restricted ordinary shares remain subject to a quarterly vesting schedule that depends on Liron’s continued service.

Does Carmel Liron’s Polyrizon (PLRZ) Form 4 include any derivative securities?

The Form 4 shows only a non-derivative transaction in Ordinary Shares and lists no derivative security positions. The derivative summary section is empty, indicating no options or similar derivative instruments reported in this particular filing.